Decoding Cipla Q1
  • WebDesk BTVI
  • Aug 07 2019

Pharma major Cipla saw its consolidated net profit rise by almost 6 per cent during the June quarter to Rs 478.19 crore. The company reported EBITDA (Earnings Before Interest, Tax, Depreciation and Amortisation) of Rs 905 crore for the June quarter, 25 per cent higher than what was reported during the corresponding quarter last year. Krishnanath Munde, Reliance Securities, says the company growth is healthy due to its business in India.